BBLG: bonebiologics.com Expected earnings per share growth for next year
Bone Biologics develops proteins for bone regeneration, which will ensure high margins during mass production. The trend in consensus EPS forecasts for the coming year clearly demonstrates market expectations, where the value of 49.80 serves as the current metric. Growth is driven by rhBMP-2 trials in Australia and an aging population, although the lack of revenue during the research stage temporarily increases unit costs for patents.
Analytical breakdowns for bonebiologics.com (BBLG)
- share price and consensus valuation forecast:
- market capitalization information:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital Bone Biologics|BBLG - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Bone Biologics Corp|BBLG - Company Total Debt Obligations|Debts to Book Capitalization Bone Biologics|BBLG - Company Long-Term Liabilities|Company Short-Term Debts Bone Biologics|Quick Liquidity bonebiologics.com
- net income and valuation ratios data:
BBLG - Company Net Income|Future Profit Bone Biologics|BBLG - Company Value to Net Income|Forward P/E Multiple Bone Biologics|BBLG - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bone Biologics|BBLG - Operating profit before depreciation charges|Net earnings per share for the last 12 months Bone Biologics|BBLG - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth bonebiologics.com|BBLG - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Bone Biologics
- sales volume and revenue indicators:
Initial company analysis:Bone Biologics Corporation, BBLG
Analyzing net income per share dynamics is critical for selecting assets with a high margin of safety, as it measures market expectations for future returns and the stability of the fundamental trend. For Bone Biologics (BBLG), the current consensus EPS growth forecast for next year reflects the probability of commercial success for bone regeneration proteins and the speed of obtaining regulatory approvals for spinal fusion.
Analysis of competing companies
BSX (Boston Scientific Inc) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year EW (Edwards Lifesciences Inc.)|Expected earnings per share growth for next year RMD (ResMed Inc.)|PODD (insulet.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Zimmer Biomet Holdings Inc ZBH|COO - Expected earnings per share growth for next year|Align Technology Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year NuVasive|TMDX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ATEC|AORT (Artivion) - Earnings growth forecast for next year|Enovis Corp (ENOV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year IART|Expected earnings per share growth for next year Establishment Labs Inc ESTA|Earnings growth forecast for next year BBNX (Beta Bionics Inc)|Earnings growth forecast for next year iradimed.com IRMD|EMBC - Net earnings per share growth forecast for next year|TNDM: Net earnings per share growth forecast for next year|AXGN (Axogen Corp) - Expected earnings per share growth for next year|SI-BONE Medical - Expected earnings per share trend next year|OFIX (Orthofix Medical Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year bioventus.com BVS|Net earnings per share growth forecast for next year OrthoPediatrics Corp. (KIDS)|Treace Medical Concepts Inc (TMCI) - Net earnings per one share growth forecast for next year|Strata Critical Medical Corp - Expected earnings per share growth for next year|Earnings growth forecast for next year Carlsmed Medical CARL|RxSight, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year ClearPoint Neuro, Inc. CLPT|Stereotaxis (STXS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year STIM (Neuronetics Inc.)|Net earnings per share growth forecast for next year Sight Sciences, Inc|Expected earnings per share growth for next year Orchestra BioMed Inc. (OBIO)|Earnings growth forecast for next year ANIK|NSPR - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Jin Medical ZJYL|VANI: Projected earnings per share growth rate for next year|XTNT: Expected earnings per share growth for next year|NeuroOne Medical Technologies Corp. - Projected earnings per share increase next year|MODD: Earnings growth forecast for next year|MYO (myomo.com) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Envoy Medical|Expected net earnings per share growth next year Vivos Therapeutics Inc. VVOS|Net earnings per share growth forecast for next year enVVeno (NVNO)|sintx.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year TNON (Tenon Medical, Inc.)|rewalk.com (LFWD) - Expected net earnings per share growth next year|AMIX: Expected earnings per share growth for next year|Expected earnings per share trend next year IVF (INVO Bioscience)|AXNX: Earnings growth forecast for next year|BIOL (Biolase Inc.) - Net earnings per share growth forecast for next year|DYNT (Dynatronics Corp) - Earnings growth forecast for next year|Paragon 28 Corp (FNA) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year INVO Bioscience, Inc. (INVO)
